Puregon 300 IU/0.36 mL solution for injection

DRUG4 trials

Sponsors

Universitair Ziekenhuis Gent, Institut De Cancerologie De L Ouest, UZ Brussel

Conditions

Breast cancerSubfertilitySubfertility in need of ICSI treatment

Phase 2

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE)

RecruitingCTIS2024-516282-37-00

Institut De Cancerologie De L OuestBreast cancer

Start: 2025-02-18Target: 100Updated: 2024-08-09

Phase 4

PPOS and CFA for elective Freeze-All ovarian stimulation cycles: a prospective cross-over study

RecruitingCTIS2023-506694-35-00

Universitair Ziekenhuis GentSubfertility

Start: 2025-01-24Target: 60Updated: 2025-04-09

A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MNC) in expected and established poor responders

RecruitingCTIS2023-509094-23-00

Universitair Ziekenhuis GentSubfertility

Start: 2022-07-15Target: 300Updated: 2025-04-28

Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study.

RecruitingCTIS2024-517312-30-00

UZ BrusselSubfertility in need of ICSI treatment

Start: 2019-06-19Target: 261Updated: 2024-10-04